C
DEAD

Serial Number

90576653

Owner

Chinook Therapeutics, Inc.

Attorney

Maury M. Tepper, III

Filing Date

Mar 12, 2021

Add to watchlist:

No watchlists yet
View on USPTO

C Trademark

Serial Number: 90576653

C is a trademark filed by Chinook Therapeutics, Inc. on March 12, 2021. The trademark is classified under Class 5 (Pharmaceuticals), Class 42 (Computer & Scientific), Class 44 (Medical Services). The application is currently no longer active.

Owner Contact Info

Chinook Therapeutics, Inc. (7 trademarks)

400 Fairview Ave North, 9th Floor
Seattle, WA 98109

Entity Type: 03

Trademark Details

Filing Date

March 12, 2021

Registration Date

Not Registered

Published for Opposition

November 23, 2021

Goods & Services

Medicines, medicinal drugs, pharmaceutical drugs, therapeutic pharmaceuticals, pharmaceutical preparations, biologics, biological preparations and therapeutic agents, all for use in the prevention and treatment of kidney, renal, nephrological, glomerular, and urological diseases, disorders and conditions

Providing information relating to the diagnostic and therapeutic properties of pharmaceutical preparations and biologic preparations for the prevention and treatment of diseases, disorders and conditions; providing a web site featuring medical information; providing medical information; providing health information; providing information relating to diagnostic, prophylactic and therapeutic properties of pharmaceuticals; provision of medical and health information in the field of prevention and treatment of kidney, renal, nephrological, glomerular, and urological diseases, disorders and conditions

Scientific research and development services; product research and development; pharmaceutical research and development; conducting clinical trials for others; providing a website featuring information in the field of medical and scientific research, product development, product testing in relation to prevention and treatment of kidney, renal, nephrological, glomerular, and urological diseases, disorders and conditions; provision of scientific research information in the field of prevention and treatment of kidney, renal, nephrological, glomerular, and urological diseases, disorders and conditions; providing a website featuring information in the field of medical and scientific research, product development and product testing; providing a website featuring medical and scientific research information in the field of investigational medical diagnostics and drugs; providing a website featuring educational information in the field of clinical research; providing medical and scientific research information in the field of clinical trials; providing medical and scientific research information in the field of pharmaceuticals and clinical trials; providing information on the subject of scientific research in the field of biochemistry and biotechnology; providing medical and scientific research information in the field of pharmaceuticals

Filing History

ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED
Oct 8, 2025 MAB6
ABANDONMENT - NO USE STATEMENT FILED
Oct 8, 2025 ABN6
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Jul 11, 2024 EXRA
SOU EXTENSION 5 GRANTED
Jul 11, 2024 EX5G
SOU EXTENSION 5 FILED
Jul 11, 2024 EXT5
SOU TEAS EXTENSION RECEIVED
Jul 11, 2024 EEXT
TEAS WITHDRAWAL OF ATTORNEY RECEIVED-FIRM RETAINS
Feb 22, 2024 EWAF
TEAS CHANGE OF CORRESPONDENCE RECEIVED
Feb 22, 2024 TCCA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Feb 22, 2024 ARAA
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Feb 22, 2024 REAP
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Jan 6, 2024 EXRA
SOU EXTENSION 4 GRANTED
Jan 4, 2024 EX4G
SOU EXTENSION 4 FILED
Jan 4, 2024 EXT4
SOU TEAS EXTENSION RECEIVED
Jan 4, 2024 EEXT
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Feb 9, 2023 EXRA
SOU EXTENSION 3 GRANTED
Feb 7, 2023 EX3G
SOU EXTENSION 3 FILED
Feb 7, 2023 EXT3
SOU TEAS EXTENSION RECEIVED
Feb 7, 2023 EEXT
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Dec 13, 2022 EXRA
SOU EXTENSION 2 GRANTED
Dec 9, 2022 EX2G
SOU EXTENSION 2 FILED
Dec 9, 2022 EXT2
SOU TEAS EXTENSION RECEIVED
Dec 9, 2022 EEXT
TEAS CHANGE OF CORRESPONDENCE RECEIVED
Aug 5, 2022 TCCA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Aug 5, 2022 ARAA
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Aug 5, 2022 REAP
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Jun 9, 2022 EXRA
SOU EXTENSION 1 GRANTED
Jun 7, 2022 EX1G
SOU EXTENSION 1 FILED
Jun 7, 2022 EXT1
SOU TEAS EXTENSION RECEIVED
Jun 7, 2022 EEXT
APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
May 20, 2022 CHAN
TEAS CHANGE OF CORRESPONDENCE RECEIVED
May 20, 2022 TCCA
TEAS CHANGE OF OWNER ADDRESS RECEIVED
May 20, 2022 COAR
NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Jan 18, 2022 NOAM
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Nov 23, 2021 NPUB
PUBLISHED FOR OPPOSITION
Nov 23, 2021 PUBO
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Nov 3, 2021 NONP
APPROVED FOR PUB - PRINCIPAL REGISTER
Oct 20, 2021 CNSA
EXAMINER'S AMENDMENT ENTERED
Oct 20, 2021 XAEC
NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Oct 20, 2021 GNEN
EXAMINERS AMENDMENT E-MAILED
Oct 20, 2021 GNEA
EXAMINERS AMENDMENT -WRITTEN
Oct 20, 2021 CNEA
ASSIGNED TO EXAMINER
Oct 8, 2021 DOCK
NOTICE OF DESIGN SEARCH CODE E-MAILED
Jun 15, 2021 MDSC
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Jun 14, 2021 NWOS
NEW APPLICATION ENTERED
Mar 16, 2021 NWAP